The Melnyk Group

We invent novel chemistries for protein chemical synthesis and protein modification. These methodologies are a strong asset for studying the role of proteins involved in human diseases, and for discovering novel protein therapeutic strategies. In particular, we are deeply involved in the study of hepatocyte growth factor (HGF)/MET tyrosine kinase receptor signaling and the design of HGF agonists for regenerative medicine.
We are proud to announce a major collaboration with Boehringer (...)

Main research interests

There is space for plenty of discoveries


A complete list of publications can be found on my ORCID account

Education and awards

DR Oleg Melnyk
Director of Research at CNRS

The CBF team

The lab


Recent papers including in press papers & openscience archives (2020-)